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1. Introduction 
With advances in the management of acute myocardial infarction (AMI) the incidence of 
mechanical complications continues to decline. Nevertheless, when they occur, 
unfortunately, despite similar advances and growing experiences in the surgical 
management of these problems, morbidity and mortality remain high. Post-myocardial 
infarction ventricular septal defects (PI-VSD) have fascinated and challenged clinicians for 
years. The timing of presentation can be quite variable, as they tend to occur in patients 
several days after their initial cardiovascular insult (acute PI-VSD) – and unfortunately, they 
can occur in patients who appear to have been making significance progress on the road to 
recovery.  In addition, although more rare, some patients might not present until weeks, if 
not longer, after their infarction with symptoms that prompt the discovery of a chronic PI-
VSD.  Early PI-VSDs tend to be catastrophic and typically result in early death.  The 
pathophysiology is also variable and complex, but common themes include: 1) worsening 
cardiac output, often with manifestations of shock and end-organ damage, from acute left 
ventricular (LV) dysfunction and from increased left-right shunting, 2) acute right 
ventricular (RV) dysfunction from a sudden increase in pressure, volume, and flow from left 
to right shunts, and 3) pulmonary hypertension also from the increase in RV flow. Definitive 
management remains surgical, however controversies continue to exist regarding the timing 
of surgery and the role of concomitant coronary revascularization.  Unfortunately, despite 
early repair and standardization of techniques, both short and long-term outcomes remain 
less than ideal. 
2. History 
As with many cardiovascular conditions, post-myocardial infarction ventricular septal 
defects (PI-VSD) were described first at autopsy (Latham, 1845) and then pre-mortum in 
1923, many years before the pathophysiology was understood (Brunn, 1923). It was not until 
1934 that the association with coronary artery disease was described (Sager, 1934).  The first 
report of a surgical repair came in 1956 when Denton Cooley described the surgical 
management in a patient 9 weeks after the initial diagnosis (Cooley, 1956). With advances in 
cardiovascular surgery and peri-operative management of the cardiac surgery patient there 
were increasing reports of survival in what was previously felt to be a lethal problem.  Most 
of the successful cases occurred in patients who presented in congestive heart failure many 
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weeks after their initial acute event.  It was these experiences that set the foundation for the 
belief that operative management should be delayed as long as possible to allow for scarring 
of the necrotic myocardium to provide for a more stable repair. As experiences grew – in 
terms of the initial diagnosis and surgical management – early repair was advocated, 
particularly in patients who were stable before hemodynamic deterioration and subsequent 
end-organ failure.  
3. Clinical presentation 
The incidence of PI-VSD has decreased considerably over the years with advances in 
myocardial reperfusion strategies.  Historically, up to 5% of all myocardial infractions were 
associated with mechanical complications such free-wall rupture, papillary muscle rupture, 
and PI-VSD (Agnihotri, 2008). With current treatment algorithms that advocate early and 
aggressive attempts at revascularization of the acute ischemic myocardial – such as 
thrombolytic therapy, early percutanous interventions with coronary stenting (PCI), and, 
less frequently, emergent coronary artery bypass surgery (CABG) – the overall incidence has 
dropped significantly.  Large multi-centers studies evaluating the pathophysiologies of 
acute myocardial infarctions have shown a current incidence of approximately 0.2% of all 
AMI.  With delays in therapies, or late clinical presentation, and the resulting increase in 
myocardial damage, this incidence increases up to 2%. Despite the relatively low risk of 
developing a PI-VSD, it account for a disproportionally high risk of mortality. Over 5% of all 
early deaths after AMI are attributed directly to the pathophysiologic complications of PI-
VSD (Poulsen, 2008). 
The timing of the development of a PI-VSD can be quite variable with the average time to 
clinical presentation is between 2 and 4 days, however presentation can be as few as a few 
hours after AMI or as long as several weeks.  
Patient risk factors include gender, with men at a greater risk than women (3:2 ratio), 
increasing age, and current smoking history. The mean age of presentation in GUSTO was 
62.5 years and ranged from 44 to 81 years (Crenshaw, 2000). 
4. Diagnosis 
The diagnosis of a PI-VSD must be considered in the differential in any patient presenting 
with hemodynamic impairment, particularly in the context of a sudden deterioration in a 
patient who otherwise had been doing well, either during or after an AMI. As a PI-VSD 
presents in a similar manner as other mechanical complications of AMI, such a papillary 
muscle rupture (with acute mitral regurgitation), free wall rupture (with contained 
tamponade), or severe LV failure and pulmonary edema the initial diagnosis is often 
suspected during initial investigations and confirmed with additional imaging.   
The typical presentation occurs in a patient who is otherwise recovering after initial 
management of an uncomplicated AMI. Patients often complain of recurrent chest pain from 
what is most likely new onset or recurrence of myocardial necrosis and will develop a new 
systolic murmur that can be harsh, pansystolic, and often-best ascultated at the left lower 
sternal border.  Patients can often have a bundle branch block from disruption of the septal 
conduction system and will quickly deteriorate hemodynamically with findings suggestive 
of acute cardiogenic shock.   
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With the acute clinical deterioration, a rapid assessment of the etiology is critical. Unlike 
other mechanical complications, such as papillary muscle rupture, PI-VSDs will have 
imagining confirming a left to right shunt – such as contrast injected into the left ventricle 
during catheterization crossing the defect into the RV and entering into the pulmonary 
arteries (Figure 1). Likewise, oxymetric assessment with right heart catheterization will 
demonstrate a “step-off” from the mixing of de-oxygenated RV blood with the 




Fig. 1. Representative cardiac catheterization in which contrast is injected into the left 
ventricular cavity and then crosses the defect into the right ventricle. Contrast flowing into 
the pulmonary artery is then diagnostic for a ventricular septal defect.  
4.1 Echocardiography 
Transthoracic echocardiography (TTE) remains the cornerstone of the non-invasive 
assessment of PI-VSD (Kishon, 1993). TTE is indicated in any patient who presents with 
evidence of acutely impaired ventricular function or in unexplained hemodynamic 
deterioration suggests a mechanical complication following an acute myocardial infarction 
(Buda, 1991).  Echocardiography has the benefit of being able to assess both left and right 
ventricular function, the presence of potentially co-existing and confounding valvular 
diseases – typically mitral regurgitation, and with color flow imaging it can be 100% specific 
and sensitive in diagnosing a PI-VSD.  Despite the utility of TEE in the acute assessment of a 
deterioritating patient, a high index of suspicion is needed when looking for a PI-VSD as 
traditional echo windows might miss a small or apical defect. Large pericardial effusions 
might suggest an associated free wall rupture. 
www.intechopen.com




Fig. 2. Transesophageal echo, 4-chamber view, demonstration an apical VSD with from from 
the left ventricle (LV) to the right ventricle (RV).  The left atrium (LA) is also shown to 
illustrate the typical relationship of the defect to the mitral valve. 
4.2 Cardiac catheterization 
Since patients who present with ECG and laboratory evidence of myocardial ischemia often 
undergo early cardiac catheterization with coronary angiography, this test often represents 
the initial study to suggest or confirm a diagnosis. Because the pathophysiology typically is 
associated with extensive and acute ischemia of a large territory of myocardium, it is not 
surprising that the findings at catheterization are often different than what would be 
expected for patients with a history of chronic coronary artery disease in which 
compensatory development of septal collaterals has had time to developed. During the 
acute presentation, the findings often suggest a complete occlusion of a large coronary 
artery in the setting of relatively minimal disease.  Single vessel disease is found in 64% of 
patients and since the left anterior descending (LAD) artery is often the culprit vessel this 
explains why antero-apical septal VSDs are found in 60% of cases. Conversely, acute 
occlusions of a dominant right coronary or circumflex artery accounts for the remaining 
cases that occur in the posterior septum. Seven percent have concomitant double vessel 
disease, and 29% have triple vessel disease.   
More importantly is that the cardiac catheterization might be the initial confirming 
diagnostic test. As mentioned above, quantitative assessment of oxygen step-offs, when 
performed, will demonstrate an increase in the partial pressure of oxygen (PaO2) between 
the right atrium and ventricle – diagnostic of the left to right shunt.  Left ventricular contrast 
injections, although less likely to be performed in a deteriorating patient secondary to the 
concern that additional contrast might further injure an already compromised renal 
function, is critical in patients with a suspected PI-VSD. Contrast injected into the LV will 
cross the defect (left-right shunt) and enter into the pulmonary arterial tree. This 
“pulmonary arteriogram” is characteristic for a VSD (Figure 1, see above).    
Despite what may be perceived as the obvious value of early catheterization, the value is 
debatable. Opponents of mandatory catheterization advocate that in a clinically deteriorating 
patient in whom the diagnosis is clear it delays surgical management, the dye load may 
worsen already impaired renal function, and some reports suggest that considering the 
patterns of coronary disease typically encountered that coronary revascularization is actually a 
risk factor for a poor outcome (Muehrcke DD , 1992).  Despite these theoretically arguments, 
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from a practical standpoint it is hard to argue the clear benefits of defining the coronary 
anatomy prior to a surgical intervention aimed at treating a complication of coronary – 
particularly given the long-established importance of optimal or complete revascularization.  
Again, since these patients have already undergone catheterization as part of the initial 
management of their initial ischemic event the question whether to proceed with 
catheterization is rarely encountered. However, as many of the patients develop septal rupture 
several days (or weeks) after their initial acute coronary insult, it is hard to argue the need for 
repeat cardiac catheterization if the diagnosis is clear, particularly if the nuances of the 
coronary anatomy have recently been determined.  Conversely, in less clear clinical situations, 
repeat catheterization might suggest an alternative, and potentially more likely, diagnosis such 
as acute stent thrombosis or disruption of an already unstable plaque.   
4.3 Magnetic Resonance Imaging 
Although the diagnosis is often made at the time of initial cardiac catheterization or 
echocardiography, occasionally a PI-VSD may be encountered during other diagnostic 
imaging. While patients might be too hemodynamically unstable or the presence of an intra-
aortic balloon pump (or other ferrous containing or non-MRI safe device) might preclude 
MRI, with the growing indications and utilization of MRI for operative planning, PI-VSD 
might be encountered. Patients with low ejection fractions, cardiomyopathies, or suspicion 
for unusual cardiac anatomy, might have MRI performed to assess for myocardial viability, 
fibrosis, or valvular pathology.  In these patients a PI-VSD may be an unsuspected finding 
(Figure 3). Although there is little literature describing the utility of MRI in PI-VSDs, using 
concepts derived from the literature on congenital shunts and pathology, MRI might be of 
value in assisting in defining the extent of the defect, the shunt fraction, right ventricular 
function, and other associated pathophysiology (Didier, 1986). MRI might be of additive 
value in cases of questionable catheterization or echocardiographic studies or in assessing 
the post-operative patient in which a residual shunt is suspected. Nevertheless, MRI is, in 
general, not considered a first-line imagining diagnostic tool. 
 
 
Fig. 3. Cardiac MRI demonstrating an apical defect. Gated cine images indicated a left to 
right shunt in which quantitative assessment can be used to determine the shunt fractions 
and size of the defect. 
www.intechopen.com




The pathogensis reflects two different types of rupture. The first, a simple rupture, is a direct 
through-and-through defect that is typically located anteriorly (when associated with a LAD 
territory infarct). Conversely, complex ruptures are believed to result from tracking of blood 
as it dissects thru the septum with left ventricular entry sites remote from right ventricular 
exit sites – these tracks then enlarge over time due to the pressure gradient between the left 
and right ventricle.  Multiple defects are found in 5-11% of cases and emphasized the need 
for a complex pre-operative and intra-operative assessment of all pathways to insure a 
complete repair (Edwards, 1984). Incomplete closure of residual or secondary defects can 
account for post-operative recurrences. Transmural infarcts can be quite extensive with 
defects developing to several centimeters in diameter and can often involve extensive areas 
of the left ventricular free wall. For complex defects, as blood dissects through the necrotic 
myocardium there can be further expansion and damage with loss of cellular integrity.  
With local cellular destruction there is fragmentation with degeneration of myocytes with 
enzymatic digestion and destruction. In patients who survive the acute presentation, up to 
66% develop chronic ventricular aneurysms and a third will have significant functional 
mitral regurgitation from the secondary effects on the ventricular free wall.   
The pathologic consequences and outcomes of surgery of anterior and posterior defects 
appear to be different in ways beyond what can be explained by the degree of shunting.  
Earlier autopsy studies have shown that anterior PI-VSDs were associated with 33% of the 
LV and only 10% of the RV being infarcted, while posterior defects were associated with 
only 20% of the LV and 33% of the RV being infarcted (Cummings, 1977). Particularly 
considering the acute pressure/volume overload and associated RV failure, it becomes 
understandable why posterior based defects have a worse prognosis. 
6. Natural history 
The natural history of untreated PI-VSD is also poorly understood. As advances in the acute 
and chronic management of coronary artery disease continues to evolve, so does 
complications of CAD. In general, 25% of patients with PI-VSDs die within the first 24 hours 
(Berger, 1992). Death is most likely a function of pre-existing comoribidites and potentially 
irreversible and catastrophic heart failure that comes from not only the acute pump failure 
from the precipitating infarct but also the massive acute left to right heart shunting that 
compromises systemic perfusion further. The sudden increase in pulmonary overcirculation 
also contributes to the development of significant right heart failure. For those patients who 
survive the acute event, 1, 2, and 4-week survival is 50%, 35%, and 20% respectively 
(Lemery, 1992). It is easy to appreciate that those patients who survive the first month may 
have inherently favorable factors that might further self-select for a good post-operative 
outcome. Prolonged untreated survival has been reported with up to 7% of patient 
surviving to 1 year – obviously the physiologic insult and over-circulation is minimal.  
7. Timing/indications for surgery 
The mere presence of a PI-VSD is considered an indication for surgery with the majority of 
patients undergoing urgent or emergent operative intervention. The primary goal of VSD 
closure is to reduce the end-organ damage from the combined insults of acute right 
ventricular overload/failure and systemic cardiogenic shock. 
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As soon as the diagnosis is made an intra-aortic balloon pump should be placed. Coronary 
augmentation will assist the ischemic and compromised myocardium, but more importantly 
it will unload the left ventricle and improve cardiac output, end-organ perfusion, and 
reduce pulmonary shunting and over-circulation.  However, the physiologic improvements 
with IABP and other inotropic or vasoactive medications should only be viewed as transient 
and allow for finishing the pre-operative assessment. 
Although some advocate a strategy of delayed repair, this approach is rarely successful.  The 
theory is to give the friable necrotic myocardium time (3-6 weeks) to fibrosis thereby allowing 
for an easier and more secure repair. The scarred tissue will better hold suture and less likely 
to tear apart and result in an early post-operative failure. This approach appears reasonable, 
but it is rare that patients remain stable or can be support during this time period.  While 
guidelines for delayed surgical management are lacking, this might be an option in those who 
are hemodynamically/physiologically stable with a delayed presentation, have no or minimal 
signs of pulmonary hypertension or over-circulation, and have a stable fluid balance with 
good renal function. Unfortunately, such patients are rare and less than 5-10% of all PI-VSD 
patients will survive to allow for delayed repair.  Such an approach may represent a “survival 
of the fittest” perspective in those with minimal shunting and with strict attention to medical 
comorbidities and nutrition a period of close watchful waiting may work. This approach may 
also be used to justify waiting in patients who have other severe comordities preclude 
intervention and would in theory require optimization prior to surgery. Nevertheless, it is 
hard to argue that any other problem would improve to the point of making surgery safer in 
the setting of worsening right ventricular heart failure – a problem that by itself is very 
difficult to treat both pre and post-operatively. Although, one can argue that in these patients, 
unless early surgical repair is clearly contraindicated, that their physiologic reserve combined 
to a minimal pathophysiologic insult predisposes to a good outcome regardless of whether an 
early or late repair is performed.     
8. Operative management 
The initial attempts at repairing PI-VSD followed a surgical approach similar to that for 
congenital VSDs – through a ventriculotomy in the right ventricular outflow track (RVOT) 
(Cooley, 1957). It was quickly appreciated the significant limitations of this approach.  
Firstly, in an already compromised right ventricle, the outflow tract incision only further 
reduced residual RV function. In addition, while suited for many common types congenital 
VSD’s near the aortic valve, the RVOT incision offered poor exposure of defects that tended 
to be much further down the septum towards the apex. Most importantly, because the patch 
and suture line was on the RV side, the defect was still exposed to LV pressures and 
consequently was at increased risk for patch dehiscence, early recurrence, and extension of 
the defect. Pioneering work by animal studies by Heimbecker in 1968 advocated an 
approach to the VSD thru the left ventricle in the region of the culprit vessel through 
infarcted myocardium – i.e., anterior defects approached through the anterior wall while 
posterior defects through the inferior wall.  These techniques addressed the deficiencies of a 
RVOT approach (Heimbecker, 1968). The benefits of these animal studies were subsequently 
validated clinically within several years (Javid, 1972)(Buckley, 1971) 
8.1 General considerations 
After the patient arrives in the operating room, the patient is routinely anesthetized and 
pharmacologically paralyzed. If not already in place, all patients should have arterial 
monitoring lines and a pulmonary artery (Swan-Ganz) catheter inserted. Pressures and 
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oxygen saturations should be obtained to determine shunt fractions and to assist in 
determining the completeness of repair at the end of the procedure. Given that this subset of 
patients possesses a left-to-right shunt, it is of upmost importance to avoid pharmacologic 
agents that cause pulmonary vasodilation, thus worsening the shunt, increasing pulmonary 
over-circulation, and potentially worsening right heart dysfunction. Preoperative antibiotics 
including a first generation cephalosporin, such as cefazolin, and vancomycin are 
administered.  In cases of antibiotic allergies, appropriate alternatives should be chosen. 
Median sternotomy is performed and the patient is prepared for cardiopulmonary bypass.  
Minimally invasive techniques are typically not advocated for this type of extensive and 
complex procedure in which complete exposure of heart is helpful. However, in situations of 
re-operative surgery, depending on surgeon preferences, consideration should be given to 
peripheral cannulation (i.e. femoral or axillary) prior to sternotomy as a re-entry injury to an 
already compromised and dilated RV can be catastrophic. The patient is heparized prior to 
standard aortic – right atrial cannulation. Some advocate routine bicaval venous drainage, but 
typically, as procedures on the tricuspid or mitral valves are not performed, this is not 
necessary. Cold-blood antegrade and retrograde cardioplegia is delivered via conventional 
root and coronary sinus catheters.  Topical cooling to further reduce the metabolic demands of 
the already compromised heart is also liberally used.  This author also routinely uses ice-slush 
wrapped in gauze to further cool the right ventricle to assist in reducing the temperature and 
thereby assisting in myocardial protection. Active or passive systemic cooling is performed 
with an ideal temperature of 25º-28ºC to further assist end-organ protection.   
In general, once the defect is identified, a piece of either glutaraldehyde-fixed bovine 
pericardium or Dacron is cut to not only cover the defect but a generous rim of surrounding, 
and potentially non-viable, myocardium. Continuous suture or interrupted pledgeted 
sutures are used to suture the patch to the residual septum. Tension on the repair must be 
avoided to minimize the risk of the sutures tearing through once the ventricle is pressurized 
and begins to contract. For posterior defects the patch might require anchoring to the 
annulus of the mitral valve. For cases in which the annulus of the mitral valve and/or peri-
valvular tissues is involved, mitral valve replacement may be required.     
The intra-operative approach and management of the defect is based upon the location of 
the VSD and, the need for concomitant procedures. The pre-operative assessment of the 
location of the defect is critical in determining the optimal approach to closing it. 
8.2 Apical defects 
Apical septal ruptures involve the cardiac apex, which includes the apical portion of the 
right ventricle, septum, and the left ventricle. Daggett and colleagues described the 
technique of apical amputation and repair of the PI-VSD in 1970. The initial incision is 
created through the infracted tissue of the cardiac apex. The necrotic myocardium is then 
  
 
Fig. 4. Repair of apical repair involves excising the apical defect and bringing together the 
residual edges of the left and right ventricular walls using a primary repair reinforced with 
pledgets. 
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excised until healthy muscle is exposed and deemed adequate for repair. The healthy tissues 
of the right and left ventricle are then approximated to the septum using interrupted, felt 
pledgeted, heavy Tycron suture in a mattress fashion (Figure 4).  Felt strips are placed along 
the right and left septal walls during this process to create a ‘felt sandwich’. The apical 
repair can be reinforced with a second layer of suture. Meticulous hemostasis is critical. 
 
  
Fig. 5. Left: Intra-operative view of the extensive apical infarction that has resulted in the the 
echocardiographic findings demonstrated in Figure 2. The left anterior descending artery 
(LAD) is shown. Right: The same patient after opening and debridement of the infracted 
apex. The necrotic septum is visualized with a probe in the left ventricle (LV) and the bypass 
“pump sucker” is in the right ventricle (RV). 
8.3 Anterior defects 
The anterior septal rupture involves the anterior septum as well as the anterior left ventricular 
free wall. This, as discussed earlier, is a typically a result of acute infarct of the LAD territory. 
The initial approach is via an incision in the infarcted left ventricular myocardium. The 
infarcted area is then excised and debrided back to healthy, viable myocardium. The septum is 
then inspected and necrotic tissue is excised in the same fashion. This is can be straightforward 
in a single, obvious defect.  However, great care must be taken if the defect is noted to be 
tracking through the myocardium – a finding that might not be obvious and hence a larger 
patch may be used than what would be employed to cover the defect.   
Small defects can be plicated to the right ventricular free wall using interrupted, pledgeted 
suture as first suggested by Shumacker (Shumaker, 1972). For anything other than very 
small (<1.0 cm) defects, most anterior septal infarcts will require repair with a patch. This is 
created in a fashion that will allow for a tension-free repair. Excess tension in the repair can 
lead to devastating consequences and a return trip to the operating room. 
The more complex approaches use a prosthetic patch that is anchored to the posterior wall 
of the septum using interrupted, pledgeted Tycron or Proline suture. The suture is passed 
from a right to left direction so that the patch-septum interface lies in the left ventricle, as 
opposed to the right. The anterior sutures are placed through the right ventricular free wall 
and tagged with hemostats (Figure 6). All sutures are placed prior to placing them through 
the patch. They can now be placed through the designated anterior region of the prosthetic 
patch and then through a second pledget if desired prior to tying the suture knots. The left 
ventricular free wall is then re-approximated using interrupted, mattress suture. A second 
layer of running suture is placed for reinforcement.  
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Fig. 6. Picture representation of the various steps used to repair an anterior defect with the 
patch excluding the necrotic septum from the higher pressure left ventricular cavity. The 




Fig. 7. Intra-operative picture with the apex of the heart elevated (head and aortic cannula to 
the right). The incision is through the infarcted anterior wall. The septal defect is shown in the 
middle of the cavity with circumferential sutures around a wide margin. The sutures will then 
be placed through a pericardial patch to exclude the infracted septal muscle and defect from 
the left ventricular cavity. Note:  This is from a different patient than from the images above 
8.4 Posterior defects 
The posterior or inferior septal rupture involves a transmural infarction of the myocardium 
in the posterior descending arterial distribution. The inferior wall is often thin and after 
infarction, is quite friable. For this reason, primary repair is not a durable option and is 
rarely successful. Attempt at primary repair, in which the myocardium is placed under 
tension, can have disastrous and immediate, and potentially fatal, consequences.  Hence, 
posterior/inferior septal ruptures are the most technically demanding of the PI-VSDs. 
After the heart is arrested, the inferior wall is lifted out of the pericardial well and exposed.  
The transmural infarct may involve both ventricles, or the septum and left ventricle alone.  
The transinfarct incision is created in a longitudinal fashion in the left ventricle. The 
nonviable myocardium is excised, which will create adequate exposure of the septal defect.  
The papillary muscles are inspected. If the base is involved in the infarct resulting in 
ruptured papillary muscle, then mitral valve replacement is warranted.  If a small posterior 
VSD (<1.0 cm) is identified, primary repair to the ventricular free wall using pledgetted 
suture as described earlier is satisfactory – but this situation is very rare and placement of a 
small patch may result in a more durable outcome than risking a primary repair involving 
ischemic myocardial tissue.   
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Large defects will require a tension free repair by utilizing a patch closure. This technique 
often necessitates the use of two separate patches, one dedicated to the septal repair and the 
other to the wall of the ventricle.  Principles as described previously apply. The pledgetted 
mattress sutures are placed from the right ventricle to the left along the circumference of the 
VSD.  The sutures are passed through the contoured patch and tied down. Great care should 
be taken to avoid lacerating the myocardium.  Some authors suggest placing a second 
pledget on the patch side of the repair to minimize this risk. The posterior ventricular wall is 
repaired with the second patch using mattress sutures.  Occasionally, depending on the size 
and quality of free wall myocardium, the free-edges can be approximated and closed 
primarily (and re-enforced with a pericardial or felt strip) rather than using a second patch. 
 
 
Fig. 8. Similar to anterior repairs, the high pressure left ventricular cavity is isolated from 
the necrotic septum with a patch repair.  The incision is along the distal right coronary along 
and parallel to the posterior descending artery through the infracted basal muscle. 
8.5 General principles 
Closure of the ventriculotomy is performed by folding the free edge of the patch to the edge of 
the ventricle to exclude it from the circulation. The ventriculotomy repair is then closed with a 
primary closure re-enforced with strips of either Teflon felt or pericardium.  Exclusion of the 
necrotic myocardium from the left ventricular is also important in minimizing the risk of small 
debris breaking off at any point and causing a systemic embolism.  
Regardless of the location of the ventriculotomy, it cannot be emphasized enough the 
importance of a tension free closure. Any unnecessary tension through injuried or friable 
myocardium may predispose to catastrophic and potentially fatal post-operative bleeding 
once the ventricle becomes pressurized.  In extreme cases involving extensive myocardial 
(free wall and septal) damage, temporary mechanical support with either extra-corporeal 
membrane oxygenation (ECMO) or a left ventricular assist device may help unload the 
ventricle to assist in recovery. The hypothesis behind this approach is by reducing the LV 
pressure, it will encourage recovery, reduce the pressure on the repair, and allow for further 
decision making in patients in whom there is extensive ventricular destruction and residual 
ventricular function may not be adequate to support physiologic needs (Firstenberg, 2009). 
Although the benefits of concomintant revascularization on long-term outcomes are 
debatable, complete coronary revascularization, if possible, is typically advocated 
(Heitmiller, 1986). As with other risk models for outcomes after surgery (e.g. EuroScore and 
STS models), it is the need for revascularization and the extent of underlying CAD that 
defines the long-term outcome rather than the actual performing of the procedure. Overall, 
the paradigm of complete and/or optimal revascularization should apply in cases of PI-VSD 
management.  It is hard to argue the conceptual benefits of revascularization in the setting of 
an already acutely and chronically compromised myocardium.  
9. Post-operation management 
The post-operative management of patients following successful repair should be similar to 
that of other high-risk surgical patients. However, there are several key points that need to 
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be considered. As these patients often present and are taken to the operating room in acute 
decompensated heart failure, strict attention to optimizing biventricular function is critical. 
Post-operative left ventricular dysfunction is not uncommon and, unless already in place, 
there should be a low threshold for placement of an intra-aortic balloon pump (IABP). 
While, as discussed later, the use of an IABP is often associated with worse outcomes, the 
relationship is the need for it and the potential delaying in initiating it’s use rather than the 
therapy itself that influences the outcomes. Right heart failure is common and often these 
patients require considerable therapies directed specifically at assisting in right heart 
recovery. Conventional intravenous agents such as epinephrine, milrinone, and dobutamine 
are often required – and sometimes at high doses. Inhaled agents that selectively reduce 
pulmonary vascular resistance and assist in reducing RV afterload such as inhaled nitric 
oxide (20-80 ppm) or Epoprostenol (2,500 – 20,000 ng/min) may be required (Rich, 1993). 
Ventricular arrhythmias are also common from the residual ischemic/necrotic myocardium 
(as well as secondary to the ventriculotomy) and anti-arrhythmic medications, such as 
Amiodarone, should be used liberally. In addition, as the repaired septal defect and free 
wall are often quite friable, strict attention to avoid hypertension is critical as even transient 
elevations in blood pressure can result in disruptions in the patch repair that might 
precipitate uncontrolled and fatal LV bleeding.  Any acute increase in chest tube drainage 
should raise the concern for ventricular suture line dehiscensce and there should be a low 
threshold for returning the patient to the operating room for re-exploration – however, 
excess manipulation of the heart in the search for bleeding should be avoiding at the risk of 
catastrophic suture-line tearing in a beating and pressurized ventricle. Although recovery in 
these patients is unpredictable and may be prolonged and a slow wean of inotropes may be 
required, there should be a low threshold for repeat and/or frequent echocardiographic 
assessment in a patient who is not improving as predicted. Repeat echocardiophy might 
show a residual shunt or valvular dysfunction, more importantly would be identification 
easy to correct problems, such as tamponade.   
10. Outcomes: predictors of survival 
The increasing rarity of PI-VSD implies that few centers are able to report an extensive 
series.  While several large single center experiences and outcomes have been reported, most 
summarize years of experience and may not consider the ongoing evolution in the peri-
operative management and improvement in surgical skills and judgment of these critically 
ill patients. 
Deja and colleagues reported their experience with 117 patients from the Glenfield General 
Hospital in England.  The mean age was 65 ± 8 years and there were 43 females.  Of the 117, 
76 were anterior defects while 34 were posterior. One third of patients presented in 
cardiogenic shock. The average time from AMI to the development (or diagnosis) of a PI-
VSD was 6 days and there was an additional 9-day average interval before surgical 
intervention.  There overall mortality was 37% - not including a 6.4% intra-operative 
mortality.  40% have evidence of a residual left-right shunt with 13 patients undergoing 
early re-operation with 30% mortality in the re-op group. Table 1 summarizes their overall 
results. Their overall predictors of post-operative mortality include: shock at time of 
surgery, clinical deterioration while awaiting surgery, need for concomitant CABG, and pre-
operative renal failure (as a marker for shock and organ failure). Criticisms of these results 
include that earlier surgical intervention after initial diagnosis might have resulted in less 
end-organ damage and an already compromised patient (Deja MA, 2002). 
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Overall surgical mortality (%) 37% 
Intra-operative mortality (%) 6.4 % 
ICU Stay (days) 4.8 days 
Major inotropic support 90 % 
Used of Intra-aortic balloon pump 75 % 
Need for extra-corporeal membrane oxygenation (ECMO) 2 % 
Ventilator Time (hours) 40 hours 
Tracheostomy 5% 
Continuous renal replacement 16 % 
Re-exploration/bleeding 5 % 
Stroke 5 % 
Residual shunt 40% 
Table 1. Post-Operative Complications Following Surgical Repair (From Deja MA, 2002) 
National registry data has proven useful to define the real-world experiences with the 
presentation and management of PI-VSD. In the report of 189 patients from Sweden, several 
factors were able to predictable favorable vs unfavorable short (<30 days) and long-term 
(>30) outcomes (Tables 2 and 3) (Jeppsson, 2005). 
 
Favorable Predictors Unfavorable Predictors No effect on outcome 
Short time from MI to Dx IABP Age 
Short time from Dx to OR Stroke/Coma Gender 
Short time from MI to OR Renal failure Pre-OP IABP 
Pre-operative catheterization Re-op for bleeding Pre-OP Lytic therapy 
Anterior rupture  Concomitant CABG 
  Residual shunt 
Table 2. Predictors of short-term (<30-day) survival based on National Swedish Experience 
(Adapted from Jeppsson et al.  Euro J Cardiothor Surg 2005;27:216-221). CABG: Coronary 
artery bypass surgery, Dx: Diagnosis, IABP: Intra-aortic balloon pump, MI: Myocardial 
infarction. 
 
Favorable Predictors Unfavorable 
Predictors 
No effect on outcome 
Younger age Pre-Op IABP Anterior rupture 
 Pre-Op Cath Time from MI to OR 
 Need for CABG Post-Op stroke 
 Renal Failure requiring 
dialysis 
Pre-OP Lytic therapy 
 Residual shunt Post-Op IABP 
  Re-op for bleeding 
Table 3. Predictors of Long-Term (>30 day).   See above for legend. 
In a similar national registry experience, Cerin and colleagues reported the outcomes in 58 
patients treated with PI-VSD from 1992 to 2000 in Italy (Cerin, 2003). The mean age was 73 
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years/old. Thirty-six percent presented in acute renal failure, 33% were in atrial fibrillation, 
and 22% were insulin dependent diabetics.  57% were in NYHA Class IV heart failure with 
41% in cardiogenic shock.  Intra-aortic balloon pumps were used in only 20% of patients and 
60% presented with significant mitral regurgitation.  The timing of surgery was 14 ± 12 days 
from the acute event with 76% undergoing surgery within the first 3 weeks and 31% within 
the first 24 hours. A key point is again emphasizing the importance of early diagnosis and 
surgery before the onset of shock and organ failure (Table 4). 
 
 Survivors (n=28) Death (n=30) 
Time to OR (d) 21 ± 13 11 ± 8 
OR < 24hrs 18 % 43 % 
Pre-Shock 28 % 57 % 
Pre-sPAP (mmHg) 42 ± 11 56 ± 14 
CPB time (time) 95 ± 28 126 ± 35 
Post-IABP 39 % 90 % 
Post-LVEF (%) 45 ± 2 29 ± 2 
Post-Op Renal Failure 25 % 66 % 
Table 4. Italian Registry Data.  Legend:  CPB: Cardiopulmonary bypass, IABP: Intra-aortic 
balloon pump, LVEF: Left ventricular ejection fraction, sPAP: Systolic pulmonary artery 
pressures.  Table adapted from Cerin et al.  Inter Soc Cardiovasc Surg 2003;11:149-154 
More recently, Mantovani et al reported their 19-year, single center, experience in 50 
patients. Between 1983 and 2002, 50 consecutive patients with a mean age of 66 ± 9 years 
(range: 45-81) who presented with either anterior (n=30, 60%) or posterior (n=20, 40%) PI-
VSDs.  Patients developed their defects on average 4 days post-AMI with most within the 
first week (76%) and only 2 patients presenting after 2 days. Cardiac catheterization was 
performed in 98% of patients (51% single vessel disease, 35% double, and 14% triple).  56% 
of patients required a pre-operative IABP and 74% underwent emergent surgery on average 
2 days after diagnosis of a PI-VSD. Operative mortality (within 30 days) was 36% with 6 
dying in the operating room.  Posterior defects were associated with 50% mortality versus 
25% for anterior.  Other univariate risk factors for early death included: emergent surgery 
(p=0.02); cross-clamp time >100 minutes (p=0.035); and delayed surgical intervention (>3 
days post diagnosis, p=0.0055).  Interestingly, in their experience factors not associated with 
operative mortality included: gender, extent of CAD (single vs triple vessel disease), need 
for CABG, age (>65 years), or the year of operation (before/after 1992).  In a logistic 
regression analysis, only emergent surgery (odds ration: 10.23) and a delayed treatment 
(OR: 4.03) were the only predictors of early mortality. Long-term survival was 76.5 ± 7.8 and 
56.1 ± 11.5% at 5 and 10 years. No obvious predictors of long-term survival were found in 
their analysis although patients with residual myocardium at risk from unrevascularized 
regions tended to have a worse long-term prognosis (Mantovani, 2006).         
In the GUSTO trial in which 41,021 patients were randomized to different strategies of 
reperfusion during AMI, 84 developed a PI-VSD.  34 of these were managed surgically, with 
31 (90%) undergoing early treated and 3 (10%) undergoing delayed surgery. Survival in the 
surgical group was 53% at 30 days and 47% at 1 year. Conversely, for those treated 
medically, as an indicator of the lethality of this problem, survival at 30 days and 1 year was 
6% and 3%, respectively (Crenshaw, 2000).  All patients who presented in Class III or IV 
heart failure died.  
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11. Controversial topics 
11.1 Percutaneous closure devices 
Successful application of closure devices in children with congenital VSDs combined with 
the morbidity and mortality associated with surgical management has prompted 
enthusiasm for the use of percutaneous closure devices. The role of such devices has been 
proposed for both the primary closure of acute defects and to assist in the closure of 
recurrent or residual shunts (Shah, 2005).     
While conceptually promising, initial experiences were discouraging and improvements in 
outcomes were not observed (Pienvichit, 2001). Difficulties in covering not only the actual 
defect, but also the residual necrotic myocardium predisposed to early recurrence. Early 
devices tended not to be large enough and were very difficult to position (or re-position if 
necessary).   
In addition, the lack of a overall survival benefit further illustrates that clinical outcomes are 
not only dictated by closure of the VSD, but sometimes more importantly, a function of the 
extend of the myocardial infarction – which might be inherently so extensive as to preclude 
survival. 
11.2  Mechanical support 
As discussed, despite advances in surgical and post-operative management, operative 
mortality is still 10-60%. Even with early intervention biventricular failure is often a 
significant factor in early post-operative deaths. Short and long-term mechanical support, 
beyond intra-aortic balloon counterpulsation, is a reasonable option in patients with post-
operative ventricular (left, right, or bi) failure and who are felt to be salvagable. Short-term 
support may be required as a bridge to recovery, while long-term device may be indicated 
for those with irreversible ventricular failure.   
In cases in which there is extensive ventricular infarction/failure, associated free-wall 
rupture, or when there is excessive bleeding or tension from the ventriculotomy temporary 
left ventricular support should be considered. With LVAD inflow drainage from the left 
atrium, the LV is unloaded (i.e. ‘atrialized’) and may allow time for recovery/healing prior 
to exposing the injured LV to system pressures and contractile function (Firstenberg 2009). 
Right ventricular support is also difficult following the acute volume/pressure overload of a 
PI-VSD with recovery unpredictable and potentially prolonged. Unfortunately, there is little 
data to support this use in this application other than clinical judgment and center 
experience. 
Residual shunts after repair pose a unique challenge for patient’s requiring mechanical 
support. Careful attention to left and right ventricular flows and pressures are critical to 
compensate for the residual shunt – and prevent worsening of over-circulation (Sai-
Sudhakar, 2006). If residual shunts are significant then biventricular support may allow for a 
period of recovery and stabilization prior to an attempted repair in an otherwise very high-
risk surgical patient.  
The need for mechanical support, while attractive in unstable post-operative patients, is also 
associated with difficult problems. Often there is need for aggressive anti-coagulation, the 
need for multiple surgical procedures (i.e. device change-outs, explants, etc), and overall 
patient recovery is more difficult when tethered to external VAD controllers.   
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A total artificial heart precludes native cardiac recovery and obligates transplantation, 
nevertheless, it may be an option with appropriate resources and experience in highly 
selected patient with few other comorbidities. 
11.3 Residual/recurrent defects 
Residual shunts are found in up to 25% of patients after definitive repair (Skillington, 1990). 
The etiology of residual shunts is either a missed defect at the time of initial repair, 
dehiscence of a patch (sewn to necrotic or friable tissue), or further extension of the initial 
defect. Fortunately, most residual shunts tend to be physiologically tolerated and 
spontaneous closure has been reported.  Operative re-intervention is associated with a >60% 
mortality (Jeppsson, 2005) and surgery is reserved for patients in heart failure failing 
medical management or those with large shunts (Qp:Qs>2.0) (Murashita, 2010).  Because of 
the high operative mortality with repairing residual or recurrent shunts there has been 
interest, but limited success, with percutanous closure devices (Shah, 2005).  Nevertheless, 
the role of percutaneous closure and the ideal devices are undefined (Pienvichit, 2001) and 
probably best reserved for use in those centers with extensive experience in the closure of 
congenital VSDs. 
12. Conclusions 
Post-myocardial infarction ventricular septal defects complicate up to 0.02% of acute 
myocardial infarctions. Despite advances in the surgical care of these moribund patients, 
operative mortality still approaches 50% with major risks including cardiogenic shock, renal 
failure, right and/or left ventricular failure, size of VSD, posterior/inferior locations, and 
residual VSD. While some patient may present late or benefit from a delayed repair, 
typically surgical intervention is indicated prior to irreversible end-organ damage. Repair 
techniques emphasize closure of the defect and protecting the injured septum from left 
ventricular pressures. Post-operative management is typically challenging considering the 
inherent pre-operative biventricular dysfunction and associated end-organ damage. Those 
who survive there initial event and operation tend to have favorable 5 and 10-year survivals. 
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